HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 UVEITIS

被引:47
|
作者
MOCHIZUKI, M
TAJIMA, K
WATANABE, T
YAMAGUCHI, K
机构
[1] AICHI CANC CTR, RES INST, DIV EPIDEMIOL, CHIKUSA KU, NAGOYA, AICHI 464, JAPAN
[2] UNIV TOKYO, INST MED SCI, DEPT PATHOL, MINATO KU, TOKYO, TOKYO 108, JAPAN
[3] KUMAMOTO UNIV, SCH MED, DEPT INTERNAL MED, HONJO, KUMAMOTO 860, JAPAN
关键词
D O I
10.1136/bjo.78.2.149
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The human retroviruses, HTLV-I and HIV, are playing clinically important roles in a variety of ocular disorders, particularly in uveitis. Both viruses are integrated in the genome of infected T cells. HIV-I infection causes the death of the infected T cells, thereby affecting the host defence system and causing AIDS. Subsequent opportunistic infections of ocular tissues, such as CMV retinitis, are a serious problem in clinical ophthalmology all over the world. Another human retrovirus, HTLV-I, has been known as the causative agent of T cell malignancies (ATL and T cell lymphoma) and chronic myelopathy (HAM/TSP), and is now recognised as a causative agent for a specific type of intraocular inflammation characterised by vitreous opacities with mild iritis and mild retinal vasculitis (HTLV-I uveitis). The mechanism by which HTLV-I causes uveitis is still unknown, but our recent data suggest that it is most probably an immune mediated mechanism by activated CD4 T cells infected with the virus. HTLV-I uveitis, therefore, may implicate a significant role of retroviruses in autoimmune diseases and further the pathogenesis of diseases with infection/autoimmune overlap.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 50 条
  • [31] Human T-lymphotropic virus type II in Japan
    Yoshizaki, H
    Kitamura, K
    Oki, A
    Yahara, S
    Yamanaka, R
    Fukushima, Y
    Komuro, K
    Yamazaki, S
    Honda, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (01): : 1 - 4
  • [32] Human T-lymphotropic virus type I infection
    Manns, A
    Hisada, M
    La Grenade, L
    LANCET, 1999, 353 (9168): : 1951 - 1958
  • [33] Human T-lymphotropic virus type I infection
    Tsukasaki, K
    Koeffler, P
    Tomonaga, M
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2000, 13 (02) : 231 - 243
  • [34] NUCLEOTIDE-SEQUENCE ANALYSIS OF ISOLATES OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-1 OF DIVERSE GEOGRAPHICAL ORIGINS
    RATNER, L
    PHILPOTT, T
    TROWBRIDGE, DB
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (11) : 923 - 941
  • [35] Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up
    Takahashi, T
    Takase, H
    Urano, T
    Sugita, S
    Miyata, K
    Miyata, N
    Mochizuki, M
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2000, 8 (04) : 235 - 241
  • [36] Human T-lymphotropic type-1 virus specific antibody detected in sera of HIV/AIDS patients in Ghana
    Adjei, AA
    Adiku, TK
    Ayeh-Kumi, PF
    Domfeh, AB
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 2003, 56 (02) : 57 - 59
  • [37] PREVALENCE OF HERPESVIRUS, HUMAN T-LYMPHOTROPIC VIRUS TYPE-1, AND TREPONEMAL INFECTIONS IN SOUTHEAST-ASIAN REFUGEES
    BUCHWALD, D
    HOOTON, TM
    ASHLEY, RL
    JOURNAL OF MEDICAL VIROLOGY, 1992, 38 (03) : 195 - 199
  • [38] UVEITIS ASSOCIATED WITH HUMAN T-LYMPHOTROPIC VIRUS TYPE-I - SEROEPIDEMIOLOGIC, CLINICAL, AND VIROLOGICAL STUDIES
    MOCHIZUKI, M
    WATANABE, T
    YAMAGUCHI, K
    TAJIMA, K
    YOSHIMURA, K
    NAKASHIMA, S
    SHIRAO, M
    ARAKI, S
    MIYATA, N
    MORI, S
    TAKATSUKI, K
    JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (04): : 943 - 944
  • [39] Human T-lymphotropic virus 1 neurologic disease
    Araujo, Abelardo
    Lima, Marco Antonio
    Silva, Marcus Tulius T.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2008, 10 (03) : 193 - 200
  • [40] Defective human T-lymphotropic virus Type 1 provirus in asymptomatic carriers
    Takenouchi, Hiroyuki
    Umeki, Kazumi
    Sasaki, Daisuke
    Yamamoto, Ikuo
    Nomura, Hajime
    Takajo, Ichiro
    Ueno, Shiro
    Umekita, Kunihiko
    Kamihira, Shimeru
    Morishita, Kazuhiro
    Okayama, Akihiko
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (06) : 1335 - 1343